Virtual reality buffet reveals how weight loss drugs alter food selections

NCT ID NCT06843512

Recruiting now Knowledge-focused Sponsor: Penn State University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how GLP-1 medications (like Ozempic or Wegovy) affect people's attitudes toward food and what they choose to eat. Researchers will use a virtual reality buffet to measure food selections before starting the medication and again after three months. The goal is to understand changes in food preferences and nutrient balance in 25 adults with overweight or obesity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GLP-1 medication
What this could lead to: If successful, this could help doctors understand how GLP-1 drugs change food choices, potentially leading to better nutritional guidance for people taking these medications.
What could go wrong: This is a small, early observational study with only 25 participants, so results may not apply to everyone. It does not test the drug's effectiveness or safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOOD SELECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Food Preferences obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FOOD SELECTION WEIGHT LOSS

Contacts and locations

Locations

Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University
RECRUITING

State College, Pennsylvania, 16802, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.